Clinical Trials on Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia in United Kingdom

Total 33 results

Novartis Pharmaceuticals

Completed

Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia (CAN-COVID)

Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia

Spain, United States, United Kingdom, Russian Federation, Italy, France
Novartis Pharmaceuticals
Incyte Corporation

Completed

Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID)

Cytokine Storm (Covid-19)

United States, Colombia, Turkey, Spain, United Kingdom, Germany, Peru, Russian Federation, Brazil, France, Mexico, Argentina
University of Toledo Health Science Campus

Completed

Fluoxetine to Reduce Intubation and Death After COVID19 Infection

COVID-19 | Cytokine Storm

United States
University of Alabama at Birmingham

Completed

Early Treatment of Cytokine Storm Syndrome in Covid-19

COVID-19 | Cytokine Storm

United States
University of Minnesota
General Electric Research; DARPA (Department of Defense)

Completed

UNITE Study (UMN-GE) for COVID-19

Inflammation | Covid19 | Cytokine Storm

United States
University of Minnesota
SecondWave Systems Inc.; DARPA (United States Department of Defense); MCDC (United...

Completed

UNITE Study (UMN-SW) for COVID-19

Inflammation | Covid19 | Cytokine Storm

United States
Weill Medical College of Cornell University
Swedish Orphan Biovitrum

Withdrawn

Anakinra, COVID-19, Cytokine Storm (SOBI)

Covid19 | Mechanical Ventilation Complication | Cytokine Storm

United States
Prisma Health-Upstate

Completed

Therapeutic Plasma Exchange Alone or in Combination With Ruxolitinib in COVID-19 Associated CRS

COVID19 | Cytokine Release Syndrome

United States
Olatec Therapeutics LLC
CTI Clinical Trial and Consulting Services

Terminated

Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome

Covid19 | Cytokine Release Syndrome

United States, Switzerland
Noveome Biotherapeutics, formerly Stemnion
IQVIA Biotech

Completed

Safety and Tolerability Study of IV ST266 in COVID-19 Subjects

Cytokine Release Syndrome

United States
Western Sussex Hospitals NHS Trust

Completed

COVID19-OR (SARS-CoV-2): Observation,Risk & Recovery

Exploring Risk Assessment and Recovery From COVID-19 Infection in Hospitalised Patients

United Kingdom
Anglia Ruskin University

Completed

Paediatric Inflammatory Multisystem Syndrome During COVID-19 Pandemic

Paediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-Cov-2

United Kingdom
Children's National Research Institute
National Institute of Allergy and Infectious Diseases (NIAID)

Active, not recruiting

Pediatric COVID Outcomes Study (PECOS)

Covid19 | SARS-CoV2 Infection | MIS-C Associated With COVID-19 | MIS-C Multisystem Inflammatory Syndrome in Children

United States
National Institutes of Health Clinical Center (CC)
Harvard Medical School (HMS and HSDM); National Cancer Institute (NCI); National... and other collaborators

Completed

Hospital COVID-19 Surge and Associated Mortality Risk

Volume Outcome Relationship Among COVID-19 Inpatients in US Hospitals

United States
Atlantic Health System

Completed

Nurses Caring for Patients With Covid-19

Nurse | in Northern New Jersey | Providing Care to Adults With Covid-19

United States
Memorial Sloan Kettering Cancer Center

Active, not recruiting

A Study of Risk Factors for the COVID-19 Virus Infection

COVID-19 Infections in Cancer Patients

United States
Emory University
National Cancer Institute (NCI)

Terminated

Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19 (RESCUE 1-19)

Pneumonia | Coronavirus Infection in 2019 (COVID-19) | Severe Acute Respiratory Syndrome (SARS) Pneumonia

United States
PhaseBio Pharmaceuticals Inc.

Terminated

Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS). (VANGARD)

Pneumonia | Respiratory Failure | Respiratory Insufficiency | COVID 19 | Acute Respiratory Distress Syndrome | SARS-CoV-2 | Coronavirus | Cytokine Storm | Pulmonary Edema | Cardiac Event | Respiratory Complication | Cardiac Dysfunction | Hypoxemic Respiratory Failure | Hypoxic Respiratory Failure | Cardiac Failure | Cardiac... and other conditions

United States
Massachusetts General Hospital

Recruiting

AT1001 for the Treatment of COVID-19 Related MIS-C

Covid19 | Multisystem Inflammatory Syndrome in Children

United States
National Institute of Allergy and Infectious Diseases...
Autoimmunity Centers of Excellence; Clinical Trials in Organ Transplantation...

Completed

COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C (PRISM)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Disease 2019 (COVID-19) | Multisystem Inflammatory Syndrome in Children (MIS-C)

United States
Children's Hospital of Philadelphia

Completed

Contrast Enhanced Ultrasound in COVID-19

Covid19 | Multisystem Inflammatory Syndrome in Children (MIS-C)

United States
Solve ME/CFS Initiative

Recruiting

Solve Together: A Data Collection Platform for the Collection of Patient and Control Health Information to Support Future Research That Will Accelerate Understanding of the Causes of and Possible Treatments for ME/CFS and Other Chronic Diseases, Including Post-viral Illnesses

ME/CFS | Post-Acute COVID-19 Syndrome

United States
Mesoblast International Sàrl

No longer available

Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection

Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19

United States
TScan Therapeutics, Inc.

Completed

Blood Collection Study From COVID-19 Convalescents Previously Hospitalized to Identify Immunogenic Viral Epitopes

Identify the Viral Epitopes of Memory CD8 T Cells From Individuals That Have Recovered From SARS-CoV-2 Infection | Determine Which SARS-CoV-2 Proteins Are Frequently Recognized by T Cells in Patients With Varying HLA Types

United States
AbbVie
Janssen Research & Development LLC; Pharmacyclics LLC (An AbbVie Company)

Completed

Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury (iNSPIRE)

CoronaVirus Induced Disease-2019 (COVID-19)

United States
Terry L. Wahls

Recruiting

Autoimmune Intervention Mastery Course Study (AIM)

Multiple Sclerosis | Clinically Isolated Syndrome | Fibromyalgia | Post Acute Sequelae of COVID-19

United States
APR Applied Pharma Research s.a.
Lavin Consulting, LLC

Completed

Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure (COVID-AIV)

Acute Lung Injury | Corona Virus Infection | Acute Respiratory Distress Syndrome (ARDS) | Critical COVID-19 With Respiratory Failure

United States
Masonic Cancer Center, University of Minnesota

Terminated

Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies

Cytokine Release Syndrome | Immune and Microbial Reconstitution | Systemic Viral Infection | Acute-graft-versus-host Disease | Chronic Graft-versus-host-disease | Recurrent Malignancy | Allogenic Related Donors | Cell Therapy/Immunotherapy Patients

United States
Wilkes University

Completed

Assessment of Analgesics and Sedatives in Mechanically Ventilated Patients With COVID-19

COVID-19 | Iatrogenic Disease | ARDS | Withdrawal Syndrome

United States
Emory University
National Cancer Institute (NCI)

Withdrawn

Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection)

Coronary Artery Disease | Diabetes Mellitus | Chronic Obstructive Pulmonary Disease | Cerebrovascular Accident | Chronic Renal Failure | Malignant Neoplasm | SARS Coronavirus 2 Infection

United States
Neuroganics LLC
Ramos Injury Law Firm

Recruiting

National Vaccine Adverse Event Reporting Survey and Etiology (NVAERS)

COVID-19 | Vaccine Adverse Reaction | Vaccine Reaction | Vasculitis | Neuritis | Thrombocytopenia | Influenza | Corona Virus Infection | Blood Clot | Guillain-Barré | Vaccine or Biological Substance, Unspecified Causing Adverse Effects in Therapeutic Use | GWAS | Genetic Sequencing

United States
Duke University
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) (POPS or POP02)

Heart Failure | Pain | Pneumonia | Hypertension | Edema | Hemophilia | Insomnia | Pulmonary Arterial Hypertension | Coagulation Disorder | Asthma in Children | Down Syndrome | Attention Deficit Hyperactivity Disorder | Bronchopulmonary Dysplasia | Hypokalemia | Hyperphosphatemia | Primary Hyperaldosteronism | Adrenal Insufficiency and other conditions

United States, Canada
OMNI Medical Services, LLC
OMNI Medical Services Inc

Recruiting

Outcomes Mandate National Integration With Cannabis as Medicine (OMNI-Can)

Depression | COVID-19 | Epilepsy | Multiple Sclerosis | Glaucoma | Cancer | Covid19 | Chronic Pain | Parkinson Disease | Inflammatory Bowel Diseases | Hepatitis C | Insomnia | HIV/AIDS | Amyotrophic Lateral Sclerosis | Fibromyalgia | Anxiety | Bipolar Disorder | Seizures | Crohn Disease | Traumatic Brain Injury | Ulcerative Colitis | Sickle... and other conditions

United States

Clinical Trials on Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations